Skip to main content
. 2020 Sep 23;7:508. doi: 10.3389/fmed.2020.00508

Table 4.

Aggregate ranking of Core Recommendations (question 5, veterinary medicine).

Number Core Recommendations Totala
32 Transform the regulatory framework for innovative veterinary medicines 14
39 Develop new approaches to improve the benefit-risk assessment of veterinary medicinal products 8
37 Collaborate with stakeholders to modernize veterinary pharmacoepidemiology and pharmacovigilance 6
33 Reinforce and further embed application of the 3Rs principles 4
40 Continue to promote the responsible use of antimicrobials and their alternatives 4
43 Promote and support development of veterinary vaccines 4
34 Facilitate implementation of novel manufacturing models 3
41 Coordinate Network activities to improve data collection on antimicrobial use in animals 3
44 Develop network-led partnerships with academia to undertake fundamental research in strategic areas of regulatory science 3
45 Leverage collaborations between academia and network scientists to address rapidly emerging regulatory science research questions 3
36 Apply the latest scientific principles to the assessment of the safety of residues of veterinary medicines 2
46 Identify and enable access to the best expertise across Europe and internationally 2
47 Disseminate and exchange knowledge, expertise, and innovation across the network and to its stakeholders 2
35 Update Environmental Risk Assessments in line with the latest scientific knowledge 1
38 Develop new and improved communication and engagement channels and methods to reach out to stakeholders 0
42 Engage with stakeholders to minimize the risks of anti-parasitic resistance 0
a

Total times chosen as first, second, or third most important.